Low educational achievement during childhood predicts a number of adverse outcomes in adulthood, including greater risk of low socioeconomic status, poor health, suicidal behavior, and premature death.
Although the American Academy of Pediatrics has published thorough guidelines and recommendations for screening for developmental disorders, many clinicians have not incorporated screening into routine well visits.
The determination of an ADHD treatment regimen can be time-consuming, requiring gradual upward dose titration and trial and error and often resulting in delays in symptom remission, premature termination of treatment, and frustration.
Children with attention problems in the first period experienced greater changes in food responses, emotional overeating, and satiety responsiveness by the second period.
Children receiving ADHD medication were older, had a higher prevalence of autism, and had more comorbid conditions than children not receiving medication.
Healthcare utilization and expenditures on psychiatric and somatic disorders at 18 years were significantly higher in patients with a childhood diagnosis of ADHD for most outcomes.
Nearly 14 percent of children aged 3 to 17 years had ever been diagnosed with attention-deficit/hyperactivity disorder or a learning disability in 2016 to 2018.
